PHRM.L Regulatory News (PHRM)

18 January 2016

Phorm Corporation Limited

("Phorm" or the "Company")

Subscription to raise approximately US$1 million gross

and Operational Update

Phorm (AIM: PHRM), a leading advertising-technology company and first party data platform provider, is pleased to announce that it has raised approximately US$1 million before expenses via a subscription for 44,821,076 new ordinary shares of nil par value each in the capital of the Company (the "Subscription Shares") at a price of 1.55 pence per Subscription Share (the "Subscription").

Phorm intends to use the net proceeds raised from the Subscription for the group's general working capital purposes. The Subscription Shares will represent approximately 4.36 per cent. of the Company's enlarged issued share capital. The Subscription is conditional upon admission of the Subscription Shares to trading on AIM ("Admission").

The closing mid-market price of the Company's existing ordinary shares on 15 January 2016 (being the latest practicable business day prior to the date of this announcement) was 1.625 pence per share. Application will be made to the London Stock Exchange plc for the Subscription Shares to be admitted to trading on AIM. It is expected that Admission of the Subscription Shares will become effective and that dealings in the Subscription Shares will commence on AIM at 8.00 a.m. on 22 January 2016. The Subscription Shares will be fully paid and will rank pari passu in all respects with the Company's existing ordinary shares. Following Admission, the total issued ordinary share capital of the Company will comprise 1,028,089,892 ordinary shares.

Operational Update

Significant Reduction in Cash Burn Rate

In the Company's Interim Results for the six months to 30 June 2015, announced on 30 September 2015, Phorm stated that its monthly average cash burn rate was US$2.5 million per month for H1 2015 (representing a 31 per cent. decrease compared to H1 2014) which was targeted to be reduced to an average monthly cash burn rate of approximately US$1.3 million per month by December 2015.

Phorm is pleased to announce that, during Q4 2015, the Company identified and implemented additional significant cost savings, with a resultant average cash burn rate for H2 2015 of approximately US$1.5 million per month.

The Board is currently forecasting a further decrease in the Company's average cash burn rate to between US$0.63 million and US$0.71 million per month during 2016, with the forecast total cash requirement for 2016 being between US$7.5 million and US$8.5 million.

The anticipated reduction in the Company's cash burn rate is expected to be achieved through a combination of increased cash receipts from revenue growth, gross margin improvement and the implementation of further cost reductions.

Internet Service Provider ("ISP") Update

Phorm continues to be engaged in detailed discussions with several ISPs, in both the United States and Europe, which are at various stages. Recently, there have been noticeably increased levels of interest from certain ISPs in monetising their data by deploying such data to support ad serving. From the Company's discussions with ISPs, the Directors are confident in their belief that the Company's full service product set is unparalleled in the industry.

CBAN Business

Phorm's cookie based advertising network (CBAN) offering continues to ramp-up in the United States, through the Company's direct sales efforts, and in the United Kingdom via its channel partner, Insomnis Media.

In the United States marketplace, Phorm continues to expand its client list of major brands for which it is delivering advertising, with clients in the insurance, ISP and multiple systems operators, consumer electronic manufacturing and leisure sectors. The Company is also seeing traction in consumer packaged goods, and e-commerce and with large media planning and buying agencies.

Video

The Company has recently started to serve audiences for performance and video ad networks which, although currently still at an early stage, the Board believes has the potential to become a meaningful source of revenue during the 2016 financial year.

-Ends-

For further information please contact: 

Phorm Corporation Limited

Timothy Smith (Chief Executive Officer) +44 (0) 20 3397 6001

Mirabaud Securities LLP (Broker) +44 (0) 20 7321 2508

Jason Woollard 

Peter Krens

Strand Hanson Limited (Nominated Adviser) +44 (0) 20 7409 3494

James Harris Matthew Chandler James Dance

About Phorm:

Phorm is a leading advertising-technology and first party data platform provider that enables brands and publishers to address online users with personalised content and advertising. Phorm's innovative platform delivers a more interesting online experience for the user and addressable campaign results for marketers. For more information, please visit: www.phorm.com